The impact of mammographic screening on breast cancer mortality in Europe: A review of observational studies

Journal of Medical Screening

Volumn 19, Issue SUPPL. 1, 2012, Pages 14-25

  Broeders, Mireille ^a   Moss, Sue ^b   Nystrom, Lennarth ^c   Njor, Sisse ^d   Jonsson, Hakan ^c   Paap, Ellen ^a   Massat, Nathalie ^b   Duffy, Stephen ^b   Lynge, Elsebeth ^d   Paci, Eugenio ^e  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UMEÅ UNIVERSITY   (Sweden)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; EARLY DIAGNOSIS; EUROPE; FEMALE; HUMAN; MAMMOGRAPHY; MASS SCREENING; MORTALITY; REVIEW; STATISTICS;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; EUROPE; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING;

EID: 84868088444     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2012.012078     Document Type: Article

References (87)

1. Shapiro S. Screening: Assessment of current studies. Cancer 1994;74(Suppl):231-8
2. Gotzsche P, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-34
3. Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-2
4. Freedman DA, Pettiti DB, Robins J. On the efficacy of screening for breast cancer. Int J Epidemiol 2004;33:43-55
5. Duffy SW, Tabá r L, Viták B, et al. The Swedish Two-County Trial of mammographic screening: Cluster randomisation and end point evaluation. Ann Oncol 2003;14:1196-8
6. Jørgensen KJ, Keen JD, Gøtzsche PC. Is mammographic screening justifiable considering its substantial overdiagnosis and minor effect on mortality? Radiology 2011;260:621-7
7. Corder AP. Screening for breast cancer. 'Mega-trial' needed. BMJ 2010;341:c4453
8. Gelmon KA, Olivotto I. The mammography screening debate: Time to move on [Commentary]. Lancet 2002;359:904-5
9. Gøtzsche PC, Jørgensen KJ. The breast screening programme and misinforming the public. J R Soc Med 2011;104:361-9
10. Fletcher SW, Elmore JG. Mammographic screening for breast cancer. N Engl J Med 2003;348:1672-80
11. Baines CJ. Mammography screening: Are women really giving informed consent? J Natl Cancer Inst 2003;95:1508-11
12. Thornton H, Edwards A, Baum M. Women need better information about routine mammography. BMJ 2003;327:101-3
13. von Karsa L, Anttila A, Ronco G, et al. Cancer Screening in the European Union. Report on the Implementation of the Council Recommendation on Cancer Screening - First report. European Commission, 2008
14. Gabe R, Duffy SW. Evaluation of service screening mammography in practice: The impact on breast cancer mortality. Ann Oncol 2005;16(Suppl 2):ii153-562
15. van Schoor G, Moss SM, Otten JDM, et al. Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer 2011;104:910-4
16. Schopper D, de Wolf C. How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer 2009;45:1916-23
17. Lynge E, Braaten T, Njor SH, et al. Mammographic activity in Norway 1983 to 2008. Acta Oncol 2011;50:1062-7
18. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies and the hierarchy of research designs. N Engl J Med 2000;342:1887-92
19. IARC Working Group on the Evaluation of Cancer Preventive Strategies. Breast cancer screening. In: Vainio H, Bianchini F, eds. IARC handbooks of cancer prevention. Vol 7. Lyon: IARC Press, 2002
20. Jatoi I, Miller AB. Why is breast-cancer mortality declining? Lancet Oncol 2003;4:251-4
21. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: Comparison of observed with predicted mortality. BMJ 2000;321:665-9
22. Jonsson H, Nystrom L, Törnberg S, Lenner P. Service screening with mammography of women aged 50-69 years in Sweden: Effects on mortality from breast cancer. J Med Screen 2001;8:152-160
23. Njor S, Nyström L, Moss S, et al. Breast cancer mortality after start of service mammography screening in Europe. A review of incidence based mortality studies. J Med Screen 2012; supplement
24. Walter SD. Mammographic screening: Case-control studies. Ann Oncol 2003;14:1190-2
25. Verbeek AL, Broeders MJ. Evaluation of cancer service screening: Case referent studies recommended. Stat Methods Med Res 2010;19:487-505
26. Paap E, Verbeek ALM, Puliti D, Paci E, Broeders MJM. Breast cancer screening case-control study design: Impact on breast cancer mortality. Ann Oncol 2011;22:863-9
27. Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Sturmans F, Day NE. Reduction of breast cancer mortality through mass screening with modern mammography; first results of the Nijmegen Project, 1975-1981. Lancet 1984;I:1222-4
28. Moss SM, Summerley ME, Thomas BT, Ellman R, Chamberlain JO. A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer. J Epidemiol Community Health 1992;46:362-4
29. Palli D, Rosselli del Turco M, Buiatti E, et al. A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer 1986;38:501-4
30. Rothman KJ. A first course in epidemiologic principles and methods. In: Olsen J, Saracci R, Trichopoulos D, eds. Teaching epidemiology. A guide for teachers in epidemiology, public health and clinical medicine. Oxford: Oxford University Press, 2001:63-75
31. Jørgensen KJ, Zahl PH, Gøtzsche PC. Breast cancer mortality in organised mammography screening in Denmark: Comparative study. BMJ 2010;340:c1241
32. Olsen AH, Njor SH, Vejborg I, et al. Breast cancer mortality in Copenhagen after the introduction of mammography screening: A cohort study. BMJ 2005;330:220
33. Wu JC, Anttila A, Yen AM, et al. Evaluation of breast cancer service screening programme with a Bayesian approach: Mortality analysis in a Finnish region. Breast Cancer Res Treat 2010;121:671-8
34. Anttila A, Sarkeala T, Hakulinen T, Heinävaara S. Impacts of the Finnish service screening programme on breast cancer rates. BMC Public Health 2008;8:38
35. Sarkeala T, Heinävaara S, Anttila A. Organised mammography screening reduces breast cancer mortality: A cohort study from Finland. Int J Cancer 2008;122:614-9
36. Sarkeala T, Heinävaara S, Anttila A. Breast cancer mortality with varying invitational policies in organised mammography. Br J Cancer 2008;98:641-5
37. Parvinen I, Helenius H, Pylkkänen L, et al. Service screening mammography reduces breast cancer mortality among elderly women in Turku. J Med Screen 2006;13:34-40
38. Anttila A, Koskela J, Hakama M. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen 2002;9:153-8
39. Hakama M, Pukkala E, Heikkilä M, Kallio M. Effectiveness of the public health policy for breast cancer screening in Finland: Population based cohort study. BMJ 1997;314:864-7
40. Gabe R, Tryggvadó ttir L, Sigfússon BF, Olafsdó ttir GH, Sigurdsson K, Duffy SW. A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 2007;48:948-55
41. Gorini G, Zappa M, Miccinesi G, Paci E, Seniori Constantini A. Breast cancer mortality trends in two areas of the province of Florence, Italy, where screening programmes started in the 1970s and 1990s. Br J Cancer 2004;90:1-4
42. Paci E, Giorgi D, Bianchi S, et al. Assessment of the early impact of the population-based breast cancer screening programme in Florence (Italy) using mortality and surrogate measures. Eur J Cancer 2002;38:568-73
43. Puliti D, Miccinesi G, Collina N, et al. Effectiveness of service screening: A case-control study to assess breast cancer mortality reduction. Br J Cancer 2008;99:423-7
44. Barchielli A, Paci E. Trends in breast cancer mortality, incidence, and survival, and mammographic screening in Tuscany, Italy. Cancer Causes Control 2001;12:249-55
45. Paci E, Duffy SW, Giorgi D, et al. Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96. Br J Cancer 2002;87:65-9
46. Otten JDM, Broeders MJM, Fracheboud J, Otto SJ, de Koning HJ, Verbeek ALM. Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006. Int J Cancer 2008;123:1929-34
47. Otto SJ, Fracheboud J, Verbeek ALM, et al. Mammography screening and risk of breast cancer death: A population-based case-control study. Cancer Epidemiol Biomarkers Prev 2012;21:66-73
48. Otto SJ, Fracheboud J, Looman CWN, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: A systematic review. Lancet 2003;361:1411-7
49. Paap E, Holland R, den Heeten GJ, et al. A remarkable reduction of breast cancer deaths in screened vs unscreened women: A case-referent study. Cancer Causes Control 2010;21:1569-73
50. Broeders MJM, Verbeek ALM, Straatman H, et al. Repeated mammographic screening reduces breast cancer mortality along the continuum of age. J Med Screen 2002;9:163-7
51. Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010;363:1203-10
52. Ugarte MD, Goicoa T, Etxeberria J, Militino AF, Pollán M. Age-specific spatio-temporal patterns of female breast cancer mortality in Spain (1975-2005). Ann Epidemiol 2010;20:906-16
53. Ascunce EN, Moreno-Iribas C, Barcos Urtiaga A, et al. Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme. J Med Screen 2007;14:14-20
54. Cabanes A, Vidal E, Pérez-Gómez B, Aragonés N, López-Abente G, Pollán M. Age-specific breast, uterine and ovarian cancer mortality trends in Spain: Changes from 1980 to 2006. Cancer Epidemiol 2009;33:169-75
55. Pons-Vigués M, Puigpinó s R, Cano-Serral G, Marí-Dell'Olmo M, Borrell C. Breast cancer mortality in Barcelona following implementation of a city breast cancer-screening program. Cancer Detect Prev 2008;32:162-7
56. Haukka J, Byrnes G, Boniol M, Autier P. Trends in breast cancer mortality in Sweden before and after implementation of mammography screening. PLoS One 2011;6:e22422
57. Chen LS, Yen AM, Duffy SW, Lin WC, Chen HH. Computer-aided system of evaluation for population-based all-in-one service screening (CASE-PASS): From study design to outcome analysis with bias adjustment. Ann Epidemiol 2010;20:786-96
58. Jonsson H, Bordá s P,Wallin H, Nyström L, Lenner P. Service screening with mammography in Northern Sweden: Effects on breast cancer mortality - an update. J Med Screen 2007;14:87-93
59. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 2006;15:45-51
60. Baker SG, Kramer BS, Prorok PC. Comparing cancer mortality rates before-and-after a change in availability of screening in different regions: Extension of the paired availability design. BMC Med Res Methodol 2004;4:1-23
61. Jonsson H, Nyström L, Törnberg S, Lundgren B, Lenner P. Service screening with mammography. Long-term effects on breast cancer mortality in the county of Gävleborg, Sweden. Breast 2003;12:183-93
62. Duffy SW, Tabar L, Chen HH, et al. The impact of organized mammography service screening on breast cancer mortality in seven Swedish counties. Cancer 2002;95:458-69
63. Tabá r L, Vitak B, Chen HHT, Yen MF, Duffy SW, Smith RA. Beyond randomized controlled trials. Organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001;91:1724-31
64. Duffy SW, Tabá r L, Olsen AH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010;17:25-30
65. Allgood PC, Warwick J, Warren RM, Day NE, Duffy SW. A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 2008;98:206-9
66. Fielder HM, Warwick J, Brook D, et al. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen 2004;11:194-8
67. Quinn M, Allen E. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries. BMJ 1995;311:1391-5
68. Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003;39:1718-29
69. Törnberg S, Kemetli L, Lynge E, et al. Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes. Acta Oncol 2006;45:528-35
70. Autier P, Boniol M, La Vecchia C, et al. Disparities in breast cancer mortality trends between 30 European countries: Retrospective analysis of WHO mortality database. BMJ 2010;341:c3620
71. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: Trend analysis of WHO mortality database. BMJ 2011;343:d4411. doi: 10.1136/bmj.d4411
72. Duffy SW, Cuzick J, Tabar L, et al. Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. Appl Statist 2002;51:235-43
73. Egger M, Davey Smith G, Altman DG. Systematic reviews in health care: Meta-analysis in context. 2nd edn. London: BMJ Books, 2001
74. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011;(1):CD001877
75. Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst 2002;94:167-73
76. Lenner P, Jonsson H. Excess mortality from breast cancer in relation to mammography screening in northern Sweden. J Med Screen 1997;4:6-9
77. Nystrom L, Larsson LG, Rutqvist LE, et al. Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee. Acta Oncol 1995;34:145-52
78. Holmberg L, Duffy SW, Yen AMF, et al. Differences in endpoints between the Swedish W-E (two county) trial of mammographic screening and the Swedish overview: Methodological consequences. J Med Screen 2009;16:73-80
79. Tabar L, Duffy S, Yen MF, et al. All-cause mortality among breast cancer patients in a screening trial: Support for breast cancer mortality as an end point. J Med Screen 2002;9:159-62
80. Goldoni CA, Bonora K, Ciatto S, et al. Misclassification of breast cancer as cause of death in a service screening area. Cancer Causes Control 2009;20:533-8
81. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: Updated overview of the Swedish randomised trials. Lancet 2002;359:909-19
82. Nelson HD, Tyne K, Nalk A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: An update for the US Preventive Services Task Force. Ann Intern Med 2009;151:727-37
83. Harris R, Yeatts J, Kinsinger L. Breast cancer screening for women ages 50 to 69 years of age: A systematic review of observational evidence. Prev Med 2011;53:108-14
84. Connor RJ, Boer R, Prorok PC, Weed DL. Investigation of design and bias issues in case-control studies of cancer screening using micro-simulation. Am J Epidemiol 2000;151:991-8
85. Duffy SW. Case-control studies to evaluate the effect of mammographic screening on mortality from breast cancer. Semin Breast Disease 2007;10:61-3
86. van Schoor G, Paap E, Broeders MJ, Verbeek AL. Residual confounding after adjustment for age: A minor issue in breast cancer screening effectiveness. Eur J Epidemiol 2011;26:585-8
87. Paap E, Verbeek ALM, Puliti D, Broeders MJM, Paci E. Minor influence of self-selection bias on the effectiveness of breast cancer screening in case-control studies in the Netherlands. J Med Screen 2011;18:142-6